{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:09:05Z","timestamp":1776971345055,"version":"3.51.4"},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Natl Compr Canc Netw"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p>Photodynamic therapy (PDT) involves the administration of a photosensitizing drug and its subsequent activation by light at wave-lengths matching the absorption spectrum of the photosensitizer. Because the skin is readily accessible to light-based therapies, PDT with systemic and particularly with topical agents has become important in treating cutaneous disorders. Topical PDT is indicated for treating actinic keratosis, superficial or thin non-melanoma skin cancer, including some cases of nodular basal cell carcinoma, and some cutaneous lymphomas. Advantages of aminolevulinic acid\/methyl aminolevulinate PDT include the possibility of simultaneous treatment of multiple tumors and large surface areas, good cosmesis, and minimal morbidity, such as bleeding, scarring, or infection.<\/jats:p>","DOI":"10.6004\/jnccn.2007.0046","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T11:54:02Z","timestamp":1492170842000},"page":"531-540","source":"Crossref","is-referenced-by-count":44,"title":["Photodynamic Therapy for Non-Melanoma Skin Cancer"],"prefix":"10.6004","volume":"5","author":[{"given":"Sari M.","family":"Fien","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, Roswell Park Cancer Institute, Buffalo, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan R.","family":"Oseroff","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Roswell Park Cancer Institute, Buffalo, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/5\/5\/article-p531.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T14:32:30Z","timestamp":1551364350000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/5\/5\/article-p531.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2007.0046","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}